BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 166 filers reported holding BLUEBIRD BIO INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,087,000 | -31.2% | 7,446 | -26.0% | 0.03% | -36.6% |
| Q2 2018 | $1,580,000 | -20.0% | 10,064 | -12.9% | 0.04% | -22.6% |
| Q1 2018 | $1,974,000 | -25.9% | 11,560 | -22.7% | 0.05% | -26.4% |
| Q4 2017 | $2,664,000 | +11.8% | 14,960 | -13.7% | 0.07% | +4.3% |
| Q3 2017 | $2,382,000 | +24.2% | 17,340 | -5.0% | 0.07% | +19.0% |
| Q2 2017 | $1,918,000 | +22.4% | 18,258 | +5.9% | 0.06% | +20.8% |
| Q1 2017 | $1,567,000 | +47.3% | 17,238 | 0.0% | 0.05% | +37.1% |
| Q4 2016 | $1,064,000 | – | 17,238 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |